{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:38:07Z","timestamp":1789702687236,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases, NIH","doi-asserted-by":"crossref","award":["R01AI071223"],"award-info":[{"award-number":["R01AI071223"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"crossref","award":["P40RR012317"],"award-info":[{"award-number":["P40RR012317"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006370","name":"SBIR","doi-asserted-by":"crossref","award":["1R43AI103983"],"award-info":[{"award-number":["1R43AI103983"]}],"id":[{"id":"10.13039\/100006370","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bill and Melinda Gates Foundation to the Infectious Disease Research Institute"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.vaccine.2013.12.057","type":"journal-article","created":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T12:45:13Z","timestamp":1388839513000},"page":"1296-1303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons"],"prefix":"10.1016","volume":"32","author":[{"given":"Souvik","family":"Karmakar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Workineh","family":"Torben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayeen U.","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loc","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond T.","family":"Damian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman F.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrick","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afzal A.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"September (3)","key":"10.1016\/j.vaccine.2013.12.057_bib0005","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.trsl.2013.03.006","article-title":"New vaccines for neglected parasitic diseases and dengue","volume":"162","author":"Beaumier","year":"2013","journal-title":"Transl Res"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2013.12.057_bib0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.idc.2012.03.004","article-title":"Schistosomiasis","volume":"26","author":"Gryseels","year":"2012","journal-title":"Infect Dis Clin North Am"},{"issue":"8","key":"10.1016\/j.vaccine.2013.12.057_bib0015","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1371\/journal.pntd.0000412","article-title":"Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden","volume":"3","author":"Hotez","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2013.12.057_bib0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.actatropica.2012.04.013","article-title":"Time to set the agenda for schistosomiasis elimination","volume":"128","author":"Rollinson","year":"2013","journal-title":"Acta Trop"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.12.057_bib0025","doi-asserted-by":"crossref","first-page":"e2106","DOI":"10.1371\/journal.pntd.0002106","article-title":"Evaluation of the health-related quality of life of children in Schistosoma haematobium \u2013 endemic communities in Kenya: a cross-sectional study","volume":"7","author":"Terer","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2013.12.057_bib0030","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.4161\/hv.7.11.17017","article-title":"Schistosomiasis vaccines","volume":"7","author":"Siddiqui","year":"2011","journal-title":"Hum Vaccin"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2013.12.057_bib0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","article-title":"Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk","volume":"6","author":"Steinmann","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"September (9541)","key":"10.1016\/j.vaccine.2013.12.057_bib0040","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","article-title":"Human schistosomiasis","volume":"368","author":"Gryseels","year":"2006","journal-title":"Lancet"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.12.057_bib0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pt.2011.10.008","article-title":"A review of female genital schistosomiasis","volume":"28","author":"Kjetland","year":"2012","journal-title":"Trends Parasitol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2013.12.057_bib0050","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/tmi.12165","article-title":"HIV and Schistosoma haematobium prevalences correlate in sub-Saharan Africa","volume":"18","author":"Ndeffo Mbah","year":"2013","journal-title":"Trop Med Int Health"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2013.12.057_bib0055","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/COH.0b013e328351b9e3","article-title":"The effects of schistosomiasis on HIV\/AIDS infection, progression and transmission","volume":"7","author":"Secor","year":"2012","journal-title":"Curr Opin HIV AIDS"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2013.12.057_bib0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0925-4439(93)90087-H","article-title":"Characterization of Ca(2+)-dependent neutral protease (calpain) from human blood flukes, Schistosoma mansoni","volume":"1181","author":"Siddiqui","year":"1993","journal-title":"Biochim Biophys Acta"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2013.12.057_bib0065","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.4049\/jimmunol.151.12.7057","article-title":"Characterization of a C3 receptor on the envelope of Schistosoma mansoni","volume":"151","author":"Silva","year":"1993","journal-title":"J Immunol"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2013.12.057_bib0070","doi-asserted-by":"crossref","first-page":"802","DOI":"10.2307\/3281488","article-title":"Complement and 5-HT increase phosphatidylcholine incorporation into the outer bilayers of Schistosoma mansoni","volume":"72","author":"Young","year":"1986","journal-title":"J Parasitol"},{"issue":"6","key":"10.1016\/j.vaccine.2013.12.057_bib0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/gb-2007-8-6-218","article-title":"The calpains: modular designs and functional diversity","volume":"8","author":"Croall","year":"2007","journal-title":"Genome Biol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.12.057_bib0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1074\/mcp.M500287-MCP200","article-title":"Proteins exposed at the adult schistosome surface revealed by biotinylation","volume":"5","author":"Braschi","year":"2006","journal-title":"Mol Cell Proteomics"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.12.057_bib0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.exppara.2004.11.001","article-title":"Schistosoma japonicum: localization of calpain in the penetration glands and secretions of cercariae","volume":"109","author":"Kumagai","year":"2005","journal-title":"Exp Parasitol"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2013.12.057_bib0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2307\/3282583","article-title":"Effects of serotonin (5HT) and complement C3 on the synthesis of the surface membrane precursors of adult Schistosoma mansoni","volume":"75","author":"Zhou","year":"1989","journal-title":"J Parasitol"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2013.12.057_bib0095","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00436-009-1646-z","article-title":"Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine","volume":"105","author":"Ahmad","year":"2009","journal-title":"Parasitol Res"},{"issue":"May (21)","key":"10.1016\/j.vaccine.2013.12.057_bib0100","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/j.vaccine.2009.02.096","article-title":"Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model","volume":"27","author":"Ahmad","year":"2009","journal-title":"Vaccine"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2013.12.057_bib0105","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1086\/651147","article-title":"Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine","volume":"201","author":"Zhang","year":"2010","journal-title":"J Infect Dis"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2013.12.057_bib0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.parint.2004.01.007","article-title":"Research on calpain of Schistosoma japonicum as a vaccine candidate","volume":"53","author":"Ohta","year":"2004","journal-title":"Parasitol Int"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.12.057_bib0115","first-page":"386","article-title":"Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicum","volume":"69","author":"Ohta","year":"2001","journal-title":"Infect Immun"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2013.12.057_bib0120","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/infdis\/jir545","article-title":"Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic","volume":"204","author":"Ahmad","year":"2011","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.12.057_bib0125","doi-asserted-by":"crossref","first-page":"e16333","DOI":"10.1371\/journal.pone.0016333","article-title":"Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant","volume":"6","author":"Coler","year":"2011","journal-title":"PLoS ONE"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.12.057_bib0130","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-3024.2008.01091.x","article-title":"Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni","volume":"31","author":"Ahmad","year":"2009","journal-title":"Parasite Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2013.12.057_bib0135","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-3024.2009.01181.x","article-title":"Sm-p80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection with Schistosoma mansoni in mouse","volume":"32","author":"Zhang","year":"2010","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2013.12.057_bib0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2172-11-31","article-title":"Duplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of new world cutaneous leishmaniasis","volume":"11","author":"Espitia","year":"2010","journal-title":"BMC Immunol"},{"issue":"August (23)","key":"10.1016\/j.vaccine.2013.12.057_bib0145","doi-asserted-by":"crossref","first-page":"15085","DOI":"10.1016\/S0021-9258(18)98590-X","article-title":"Characterization of cDNA clones encoding a novel calcium-activated neutral proteinase from Schistosoma mansoni","volume":"266","author":"Andresen","year":"1991","journal-title":"J Biol Chem"},{"issue":"December (2)","key":"10.1016\/j.vaccine.2013.12.057_bib0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0166-6851(91)90078-K","article-title":"Molecular cloning and sequence analysis of a calcium-activated neutral protease (calpain) from Schistosoma mansoni","volume":"49","author":"Karcz","year":"1991","journal-title":"Mol Biochem Parasitol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.12.057_bib0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0014-4894(91)90121-C","article-title":"Schistosoma mansoni: characterization and identification of calcium-binding proteins associated with the apical plasma membrane and envelope","volume":"72","author":"Siddiqui","year":"1991","journal-title":"Exp Parasitol"},{"issue":"3","key":"10.1016\/j.vaccine.2013.12.057_bib0160","doi-asserted-by":"crossref","first-page":"e1002605","DOI":"10.1371\/journal.ppat.1002605","article-title":"A novel mouse model of Schistosoma haematobium egg-induced immunopathology","volume":"8","author":"Fu","year":"2012","journal-title":"PLoS Pathog"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2013.12.057_bib0165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/00034983.1978.11719309","article-title":"The development of Schistosoma haematobium in the hamster","volume":"72","author":"Ghandour","year":"1978","journal-title":"Ann Trop Med Parasitol"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2013.12.057_bib0170","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1365-3156.1996.d01-52.x","article-title":"Histopathological observations in new and classic models of experimental Schistosoma haematobium infections","volume":"1","author":"Vuong","year":"1996","journal-title":"Trop Med Int Health"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2013.12.057_bib0175","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0022149X00014024","article-title":"Schistosoma haematobium in the baboon (Papio anubis): assessment of protection levels against either a single mass challenge or repeated trickle challenges after vaccination with irradiated schistosomula","volume":"69","author":"Reid","year":"1995","journal-title":"J Helminthol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2013.12.057_bib0180","first-page":"187","article-title":"Use of human infection and vaccine-protected baboon sera for the characterisation of cloned Schistosoma haematobium antigen genes","volume":"44","author":"Renganathan","year":"1993","journal-title":"Trop Med Parasitol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.12.057_bib0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4269\/ajtmh.1989.40.55","article-title":"Pathology resulting from the administration of a live attenuated anti-Schistosoma haematobium vaccine in baboons","volume":"40","author":"Byram","year":"1989","journal-title":"Am J Trop Med Hyg"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2013.12.057_bib0190","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.4049\/jimmunol.181.3.1767","article-title":"IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4","volume":"181","author":"Avery","year":"2008","journal-title":"J Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2013.12.057_bib0195","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1471-4922(03)00139-9","article-title":"Class and subclass selection in parasite-specific antibody responses","volume":"19","author":"Garraud","year":"2003","journal-title":"Trends Parasitol"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2013.12.057_bib0200","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.4049\/jimmunol.169.8.4298","article-title":"Isotype switching by human B cells is division-associated and regulated by cytokines","volume":"169","author":"Tangye","year":"2002","journal-title":"J Immunol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2013.12.057_bib0205","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/intimm\/dxq429","article-title":"Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy","volume":"22","author":"Mattos","year":"2010","journal-title":"Int Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.12.057_bib0210","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ndt\/gfg616","article-title":"Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy","volume":"19","author":"Ohtani","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2013.12.057_bib0215","doi-asserted-by":"crossref","first-page":"e781","DOI":"10.1016\/j.ijid.2010.02.2266","article-title":"Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice","volume":"14","author":"Ahmad","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"June (21\u201322)","key":"10.1016\/j.vaccine.2013.12.057_bib0220","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/S0264-410X(03)00159-2","article-title":"Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation","volume":"21","author":"Siddiqui","year":"2003","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2013.12.057_bib0225","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1128\/IAI.71.7.3844-3851.2003","article-title":"Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte\u2013macrophage colony-stimulating factor and interleukin-4","volume":"71","author":"Siddiqui","year":"2003","journal-title":"Infect Immun"},{"issue":"May (2)","key":"10.1016\/j.vaccine.2013.12.057_bib0230","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.actatropica.2011.01.010","article-title":"Schistosoma mansoni antigen Sm-p80: prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum)","volume":"118","author":"Zhang","year":"2011","journal-title":"Acta Trop"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13018008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13018008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T09:05:07Z","timestamp":1688893507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13018008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0264410X13018008"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}